MyChesCo on MSN21h
Cabaletta Bio Reveals Promising Clinical Data for Autoimmune Therapy
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) shared new and updated results from its RESET clinical development ...
rheumatologyadvisor1d
Arthralgia, EIMs Linked to Risk for IBD-Related Arthritis in Crohn Disease
Extraintestinal manifestations and arthralgia are significant predictors of IBD-related arthritis among patients with CD, while sacroiliitis was not associated.
2minutemedicine.com6d
Dazukibart is effective in reducing disease activity in adults with refractory dermatomyositis
CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2.
Yahoo Finance6d
Abcuro secures $200m as it eyes approval for rare muscle disease drug
US-based biotech Abcuro has raised $200m to advance the development of its monoclonal antibody ulviprubart in the rare muscle ...